在晚期细胞癌中揭示苏尼蒂尼布的双重血管并发症
Stella Nabirye1,2, Doreen Nakagaayi1, Wanzhu Zhang1
1Adult Cardiology, Uganda Heart Institute, Kampala, UGA.
Cureus
|November 28, 2025
概括
苏尼蒂尼布是一种氨酸激酶抑制剂 (TKI),可在晚期细胞癌 (RCC) 患者中引起严重的血栓. 警对于管理这些血管并发症至关重要,特别是那些有其他危险因素的人.
科学领域:
- 在瘤学瘤学.
- 血管医学 血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 像苏尼蒂尼布这样的氨酸激酶抑制剂 (TKIs) 在晚期细胞癌 (RCC) 治疗中至关重要.
- 血栓栓塞栓并发症是已知的风险,但尚未完全理解.
- 动脉事件虽然很少发生,但会带来重大的临床挑战.
研究的目的:
- 在接受sunitinib治疗的RCC患者中报告联合静脉和动脉血栓的病例.
- 突出TKI治疗可能导致严重血管事件的可能性.
- 强调在管理这些并发症时需要进行风险评估和警.
主要方法:
- 一个年轻的状细胞携带者男性患有转移性RCC的病例报告.
- 患者接受了腎切除術后的蘇尼提尼布.
- 记录了广泛的静脉血栓形成和随后的心肌梗塞的发展,尽管服用抗凝药.
主要成果:
- 该患者经历了上肢静脉血栓和ST升高心肌梗塞 (STEMI).
- 冠状动脉扫描证实了动脉封闭,通过皮肤冠状动脉干预进行治疗.
- 这说明了静脉和动脉血栓瘤在接受sunitinib治疗的RCC患者中的融合.
结论:
- 在转移性RCC中,苏尼蒂尼布治疗可能导致严重的,可能危及生命的血管并发症.
- 患有额外前血栓性因素的患者可能面临更高的风险.
- 临床警,早期识别和量身定制的干预措施对于TKI治疗期间的患者安全至关重要.
相关概念视频
01:24Hemodialysis II: Procedure and Complications
573
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
573
01:24Chronic Kidney Disease II: Clinical Manifestations
529
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
529
01:11Renal Failure: Dose Adjustments
407
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
407
01:19Imaging Studies VII: Vascular Imaging
292
DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
292
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
888
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
888
01:26Kidney Transplant II: Surgical Procedure
289
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
289